Helen M. Thackray

Pediatrics

111 Michigan Ave NW
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.

Journal: Blood

Published: February 07, 2022

Extrapolation as a Default Strategy in Pediatric Drug Development.

Extrapolation as a Default Strategy in Pediatric Drug Development.

Journal: Therapeutic innovation & regulatory science

Published: July 18, 2021

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

Journal: Blood

Published: January 12, 2021

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.

Journal: Blood

Published: June 19, 2014

Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.

Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.

Journal: PloS one

Published: December 10, 2013

Showing 1-5 of 5

Last Updated: 09/26/2026